3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Thrombocythemia, Essential
1
Polycythemia Vera
1
Hypogonadism
1
Fatigue Syndrome, Chronic
1
Eunuchism
1
Interventions
ruxolitinib
4
venetoclax
1
veliparib
1
pevonedistat
1
navitoclax
1
givinostat hydrochloride
1
givinostat
1
fludarabine phosphate
1
elotuzumab
1
bomedemstat
1
Whole-Body Irradiation
1
Valganciclovir
1
Topotecan
1
Therapeutics
1
Tacrolimus
1
Sirolimus
1
Polymerase Chain Reaction
1
Peripheral Blood Stem Cell Transplantation
1
Panobinostat
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Hydroxyurea
1
Ganciclovir
1
Foscarnet
1
Flow Cytometry
1
Etoposide
1
Drug Evaluation
1
Cyclosporine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Polycythemia Vera
×
Drug Evaluation
×
Clear all
NCT02577926
2025-06-10
Ruxo-BEAT
RWTH Aachen University
Phase 2
Active not recruiting
207 enrolled